Jupiter Asset Management LTD Clovis Oncology, Inc. Transaction History

Jupiter Asset Management LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 11, 2022	SELL	$1.43 - $3.14 $43,284 - $95,044	-30,269 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$2.7 - $4.76 $81,726 - $144,080	30,269 New	30,269 $82,000
Q3 2021 Nov 10, 2021	SELL	$4.06 - $5.8 $1.05 Million - $1.5 Million	-259,196 Closed	0 $0
Q2 2021 Aug 10, 2021	BUY	$5.02 - $7.05 $1.3 Million - $1.83 Million	259,196 New	259,196 $1.5 Million

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Jupiter Asset Management LTD with notifications on news.